Berkery Noyes Report: Commercial Mergers in Healthcare Up by Volume in 2019, Down by Transaction Value

A report by the Berkery Noyes investment banking advisory firm finds an increase in commercial healthcare mergers, with transaction volume in 2019 up over 2018, though with a decrease in transaction value
Jan. 24, 2020
2 min read

A new report from the New York-based Berkery Noyes independent investment banking advisory firm has found an increase in commercial healthcare mergers, with total transaction volume in 2019 increasing by 14 percent over 2018, from 469 to 534, though total transaction value in 2019 declined by six percent over 2018, from $36.09 billion to $33.90 billion.

As the report notes, the median revenue multiple involved in those transactions shifted from 2.5x in 2018 to 2.3x in 2019. The median EBITDA multiple moved upward during this timeframe from 11.9x to 12.6x. Further, the report has found, “The segment with the largest rise in volume in 2019 over 2018 was Pharma IT with a 32 percent gain, from 31 to 41 transactions,” while “The Healthcare IT segment, which saw volume increase 11 percent on a yearly basis, accounted for nearly one-half of the industry’s aggregate volume in 2019.”

As the report notes, “Berkery Noyes tracked 1,462 Healthcare/Pharma Information and Technology transactions between 2017 and 2019, of which 286 disclosed financial terms, and calculated the aggregate value to be $85.71 billion. Based on known transaction values, we project values of 1,176 undisclosed transactions to be $14.86 billion, totaling $100.56 billion worth of transactions tracked over the past three years. Disclosed median enterprise value multiples for all segments combined in this report during the last 36 months were 2.3x revenue and 12.6x EBITDA.”

The report also noted that “The segment with the largest rise in volume in 2019 over 2018 was Pharma IT with a 32 percent gain, from 31 to 41 transactions.” What’s more, “The Healthcare IT segment, which saw volume increase 11 percent on a yearly basis, accounted for nearly one-half of the industry’s aggregate volume in 2019.”

The full report can be downloaded here.

About the Author

Mark Hagland

Mark Hagland

Mark Hagland has been Editor-in-Chief since January 2010, and was a contributing editor for ten years prior to that. He has spent 30 years in healthcare publishing, covering every major area of healthcare policy, business, and strategic IT, for a wide variety of publications, as an editor, writer, and public speaker. He is the author of two books on healthcare policy and innovation, and has won numerous national awards for journalistic excellence.

Sign up for our eNewsletters
Get the latest news and updates